node1	node2	edge_score	
DB00364	FGF2	1.0	
DB00364	EGF	1.0	
EGF		1.0
FGF2		1.0
 Adenocarcinoma, ovarian, somatic, 167000 (3)	EGF	1.0	
 Adenocarcinoma, ovarian, somatic, 167000 (3)	FGF2	1.0	
Adenomas, multiple colorectal, 608456 (3)	EGF	1.0	
Adenomas, multiple colorectal, 608456 (3)	FGF2	1.0	
Amyotrophic Lateral Sclerosis	EGF	1.0	
Amyotrophic Lateral Sclerosis	FGF2	1.0	
Anaplasia	EGF	1.0	
Anaplasia	FGF2	1.0	
Arteriosclerosis	EGF	1.0	
Arteriosclerosis	FGF2	1.0	
Arthritis, Psoriatic	EGF	1.0	
Arthritis, Psoriatic	FGF2	1.0	
Rheumatoid arthritis	EGF	1.0	
Rheumatoid arthritis	FGF2	1.0	
Asthma	EGF	1.0	
Asthma	FGF2	1.0	
Astrocytoma	EGF	1.0	
Astrocytoma	FGF2	1.0	
Atherosclerosis	EGF	1.0	
Atherosclerosis	FGF2	1.0	
Barrett Esophagus	EGF	1.0	
Barrett Esophagus	FGF2	1.0	
Malignant tumor of urinary bladder	EGF	1.0	
Malignant tumor of urinary bladder	FGF2	1.0	
Brain neoplasm	EGF	1.0	
Brain neoplasm	FGF2	1.0	
Breast-ovarian cancer, familial 1	EGF	1.0	
Breast-ovarian cancer, familial 1	FGF2	1.0	
Colon cancer	EGF	1.0	
Colon cancer	FGF2	1.0	
Malignant neoplasm of endometrium	EGF	1.0	
Malignant neoplasm of endometrium	FGF2	1.0	
Thyroid cancer, nonmedullary, 4	EGF	1.0	
Thyroid cancer, nonmedullary, 4	FGF2	1.0	
Non-small cell lung carcinoma	EGF	1.0	
Non-small cell lung carcinoma	FGF2	1.0	
Renal cell carcinoma, nonpapillary	EGF	1.0	
Renal cell carcinoma, nonpapillary	FGF2	1.0	
Squamous cell carcinoma	EGF	1.0	
Squamous cell carcinoma	FGF2	1.0	
Urothelial Carcinoma	EGF	1.0	
Urothelial Carcinoma	FGF2	1.0	
Malignant tumor of cervix	EGF	1.0	
Malignant tumor of cervix	FGF2	1.0	
Cholesteatoma	EGF	1.0	
Cholesteatoma	FGF2	1.0	
Choriocarcinoma	EGF	1.0	
Choriocarcinoma	FGF2	1.0	
Cleft Palate	EGF	1.0	
Cleft Palate	FGF2	1.0	
Colorectal cancer 1	EGF	1.0	
Colorectal cancer 1	FGF2	1.0	
Colorectal Neoplasms	EGF	1.0	
Colorectal Neoplasms	FGF2	1.0	
Craniosynostoses	EGF	1.0	
Craniosynostoses	FGF2	1.0	
Diabetes mellitus type 1	EGF	1.0	
Diabetes mellitus type 1	FGF2	1.0	
Diabetes mellitus type 2	EGF	1.0	
Diabetes mellitus type 2	FGF2	1.0	
Diabetic Nephropathies	EGF	1.0	
Diabetic Nephropathies	FGF2	1.0	
Endometriosis	EGF	1.0	
Endometriosis	FGF2	1.0	
Esophageal Neoplasms	EGF	1.0	
Esophageal Neoplasms	FGF2	1.0	
Exostoses	EGF	1.0	
Exostoses	FGF2	1.0	
Gastritis	EGF	1.0	
Gastritis	FGF2	1.0	
Glioblastoma	EGF	1.0	
Glioblastoma	FGF2	1.0	
Glioma	EGF	1.0	
Glioma	FGF2	1.0	
Goiter, multinodular 1, with or without sertoli-leydig cell tumors	EGF	1.0	
Goiter, multinodular 1, with or without sertoli-leydig cell tumors	FGF2	1.0	
Head and Neck Neoplasms	EGF	1.0	
Head and Neck Neoplasms	FGF2	1.0	
Herpes Simplex Infections	EGF	1.0	
Herpes Simplex Infections	FGF2	1.0	
Hypertension	EGF	1.0	
Hypertension	FGF2	1.0	
Pulmonary hypertension, neonatal, susceptibility to	EGF	1.0	
Pulmonary hypertension, neonatal, susceptibility to	FGF2	1.0	
Inflammation	EGF	1.0	
Inflammation	FGF2	1.0	
Inflammatory Bowel Diseases	EGF	1.0	
Inflammatory Bowel Diseases	FGF2	1.0	
Ischemia	EGF	1.0	
Ischemia	FGF2	1.0	
Kidney Diseases	EGF	1.0	
Kidney Diseases	FGF2	1.0	
Leiomyoma	EGF	1.0	
Leiomyoma	FGF2	1.0	
Chronic Lymphocytic Leukemia	EGF	1.0	
Chronic Lymphocytic Leukemia	FGF2	1.0	
Acute lymphoid leukemia	EGF	1.0	
Acute lymphoid leukemia	FGF2	1.0	
Acute myeloid leukemia	EGF	1.0	
Acute myeloid leukemia	FGF2	1.0	
Chronic myeloid leukemia	EGF	1.0	
Chronic myeloid leukemia	FGF2	1.0	
Liver Cirrhosis, Biliary	EGF	1.0	
Liver Cirrhosis, Biliary	FGF2	1.0	
Neoplasm of the liver	EGF	1.0	
Neoplasm of the liver	FGF2	1.0	
Chronic obstructive pulmonary disease	EGF	1.0	
Chronic obstructive pulmonary disease	FGF2	1.0	
Lymphoma, Large B-Cell, Diffuse	EGF	1.0	
Lymphoma, Large B-Cell, Diffuse	FGF2	1.0	
{Gastric cancer risk after H. pylori infection}, 137215 (3)	EGF	1.0	
{Gastric cancer risk after H. pylori infection}, 137215 (3)	FGF2	1.0	
Animal Mammary Neoplasms	EGF	1.0	
Animal Mammary Neoplasms	FGF2	1.0	
Melanoma	EGF	1.0	
Melanoma	FGF2	1.0	
Meningioma	EGF	1.0	
Meningioma	FGF2	1.0	
Mesothelioma, malignant	EGF	1.0	
Mesothelioma, malignant	FGF2	1.0	
Multiple Myeloma	EGF	1.0	
Multiple Myeloma	FGF2	1.0	
Secondary hypertriglyceridemia	EGF	1.0	
Secondary hypertriglyceridemia	FGF2	1.0	
Neoplasm Recurrence, Local	EGF	1.0	
Neoplasm Recurrence, Local	FGF2	1.0	
Pathologic Neovascularization	EGF	1.0	
Pathologic Neovascularization	FGF2	1.0	
Melanocytic nevus	EGF	1.0	
Melanocytic nevus	FGF2	1.0	
Obesity	EGF	1.0	
Obesity	FGF2	1.0	
Osteoarthritis	EGF	1.0	
Osteoarthritis	FGF2	1.0	
Pancreatic Neoplasms	EGF	1.0	
Pancreatic Neoplasms	FGF2	1.0	
Parkinson Disease	EGF	1.0	
Parkinson Disease	FGF2	1.0	
Pituitary adenoma	EGF	1.0	
Pituitary adenoma	FGF2	1.0	
Abnormality of the pituitary gland	EGF	1.0	
Abnormality of the pituitary gland	FGF2	1.0	
Pituitary Neoplasms	EGF	1.0	
Pituitary Neoplasms	FGF2	1.0	
Preeclampsia/eclampsia 1	EGF	1.0	
Preeclampsia/eclampsia 1	FGF2	1.0	
Precancerous Conditions	EGF	1.0	
Precancerous Conditions	FGF2	1.0	
Prostatic Diseases	EGF	1.0	
Prostatic Diseases	FGF2	1.0	
Prostatic Neoplasms	EGF	1.0	
Prostatic Neoplasms	FGF2	1.0	
Pulmonary fibrosis and/or bone marrow failure, telomere-related, 4	EGF	1.0	
Pulmonary fibrosis and/or bone marrow failure, telomere-related, 4	FGF2	1.0	
Reperfusion Injury	EGF	1.0	
Reperfusion Injury	FGF2	1.0	
Scleroderma	EGF	1.0	
Scleroderma	FGF2	1.0	
Seizures, Febrile	EGF	1.0	
Seizures, Febrile	FGF2	1.0	
Gastric ulcer	EGF	1.0	
Gastric ulcer	FGF2	1.0	
Thyroid Neoplasms	EGF	1.0	
Thyroid Neoplasms	FGF2	1.0	
Unipolar Depression	EGF	1.0	
Unipolar Depression	FGF2	1.0	
Uterine leiomyoma	EGF	1.0	
Uterine leiomyoma	FGF2	1.0	
Virus Diseases	EGF	1.0	
Virus Diseases	FGF2	1.0	
Corneal neovascularization	EGF	1.0	
Corneal neovascularization	FGF2	1.0	
Small cell lung cancer	EGF	1.0	
Small cell lung cancer	FGF2	1.0	
Cutaneous malignant melanoma 3	EGF	1.0	
Cutaneous malignant melanoma 3	FGF2	1.0	
Adenocarcinoma of lung	EGF	1.0	
Adenocarcinoma of lung	FGF2	1.0	
Esophageal carcinoma	EGF	1.0	
Esophageal carcinoma	FGF2	1.0	
Primary pulmonary hypertension	EGF	1.0	
Primary pulmonary hypertension	FGF2	1.0	
Uterine Corpus Cancer	EGF	1.0	
Uterine Corpus Cancer	FGF2	1.0	
Malignant neoplasm of brain and nervous system	EGF	1.0	
Malignant neoplasm of brain and nervous system	FGF2	1.0	
Secondary malignant neoplasm of lung	EGF	1.0	
Secondary malignant neoplasm of lung	FGF2	1.0	
Hearing Loss, Mixed Conductive-Sensorineural	EGF	1.0	
Hearing Loss, Mixed Conductive-Sensorineural	FGF2	1.0	
Tumor Progression	EGF	1.0	
Tumor Progression	FGF2	1.0	
Embryonal Carcinoma	EGF	1.0	
Embryonal Carcinoma	FGF2	1.0	
Thyroid cancer, follicular	EGF	1.0	
Thyroid cancer, follicular	FGF2	1.0	
Adrenocortical carcinoma	EGF	1.0	
Adrenocortical carcinoma	FGF2	1.0	
Intraocular melanoma	EGF	1.0	
Intraocular melanoma	FGF2	1.0	
Pancreatic Carcinoma	EGF	1.0	
Pancreatic Carcinoma	FGF2	1.0	
Papillary thyroid carcinoma	EGF	1.0	
Papillary thyroid carcinoma	FGF2	1.0	
Hepatic fibrosis	EGF	1.0	
Hepatic fibrosis	FGF2	1.0	
Malignant neoplasm of lung	EGF	1.0	
Malignant neoplasm of lung	FGF2	1.0	
Age-related macular degeneration 2	EGF	1.0	
Age-related macular degeneration 2	FGF2	1.0	
Disease Progression	EGF	1.0	
Disease Progression	FGF2	1.0	
Gastric Adenocarcinoma	EGF	1.0	
Gastric Adenocarcinoma	FGF2	1.0	
Cancer of Head and Neck	EGF	1.0	
Cancer of Head and Neck	FGF2	1.0	
Esophageal Squamous Cell Carcinoma	EGF	1.0	
Esophageal Squamous Cell Carcinoma	FGF2	1.0	
Adenocarcinoma Of Esophagus	EGF	1.0	
Adenocarcinoma Of Esophagus	FGF2	1.0	
Solid tumour	EGF	1.0	
Solid tumour	FGF2	1.0	
Carcinoma of cervix	EGF	1.0	
Carcinoma of cervix	FGF2	1.0	
Malignant mesothelioma	EGF	1.0	
Malignant mesothelioma	FGF2	1.0	
Malignant neoplasm of pancreas	EGF	1.0	
Malignant neoplasm of pancreas	FGF2	1.0	
Malignant tumor of prostate	EGF	1.0	
Malignant tumor of prostate	FGF2	1.0	
Endometrial carcinoma	EGF	1.0	
Endometrial carcinoma	FGF2	1.0	
Nevus	EGF	1.0	
Nevus	FGF2	1.0	
Recurrent tumor	EGF	1.0	
Recurrent tumor	FGF2	1.0	
Hepatitis C, Chronic	EGF	1.0	
Hepatitis C, Chronic	FGF2	1.0	
Malignant tumor of esophagus	EGF	1.0	
Malignant tumor of esophagus	FGF2	1.0	
Thyroid carcinoma	EGF	1.0	
Thyroid carcinoma	FGF2	1.0	
Malignant Glioma	EGF	1.0	
Malignant Glioma	FGF2	1.0	
Osteosarcoma	EGF	1.0	
Osteosarcoma	FGF2	1.0	
Carcinogenesis	EGF	1.0	
Carcinogenesis	FGF2	1.0	
Prostate carcinoma	EGF	1.0	
Prostate carcinoma	FGF2	1.0	
Ovarian epithelial cancer	EGF	1.0	
Ovarian epithelial cancer	FGF2	1.0	
Breast carcinoma	EGF	1.0	
Breast carcinoma	FGF2	1.0	
Lung cancer	EGF	1.0	
Lung cancer	FGF2	1.0	
Carcinoma of colon	EGF	1.0	
Carcinoma of colon	FGF2	1.0	
Stomach cancer	EGF	1.0	
Stomach cancer	FGF2	1.0	
Bladder carcinoma	EGF	1.0	
Bladder carcinoma	FGF2	1.0	
Neuroblastoma	EGF	1.0	
Neuroblastoma	FGF2	1.0	
Middle Cerebral Artery Occlusion	EGF	1.0	
Middle Cerebral Artery Occlusion	FGF2	1.0	
Malignant neoplasm of kidney	EGF	1.0	
Malignant neoplasm of kidney	FGF2	1.0	
Ovarian Neoplasms	EGF	1.0	
Ovarian Neoplasms	FGF2	1.0	
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	EGF	1.0	
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	FGF2	1.0	
Endometrial adenocarcinoma	EGF	1.0	
Endometrial adenocarcinoma	FGF2	1.0	
Squamous cell carcinoma of the head and neck	EGF	1.0	
Squamous cell carcinoma of the head and neck	FGF2	1.0	
Sarcoma, Ewing	EGF	1.0	
Sarcoma, Ewing	FGF2	1.0	
Major depressive disorder	EGF	1.0	
Major depressive disorder	FGF2	1.0	
Benign melanocytic nevus	EGF	1.0	
Benign melanocytic nevus	FGF2	1.0	
Tumor Angiogenesis	EGF	1.0	
Tumor Angiogenesis	FGF2	1.0	
Colorectal cancer	EGF	1.0	
Colorectal cancer	FGF2	1.0	
Benign Prostatic Hyperplasia	EGF	1.0	
Benign Prostatic Hyperplasia	FGF2	1.0	
Idiopathic Pulmonary Fibrosis	EGF	1.0	
Idiopathic Pulmonary Fibrosis	FGF2	1.0	
Hepatocellular carcinoma	EGF	1.0	
Hepatocellular carcinoma	FGF2	1.0	
Pulmonary arterial hypertension	EGF	1.0	
Pulmonary arterial hypertension	FGF2	1.0	
Secondary malignant neoplasm of pancreas	EGF	1.0	
Secondary malignant neoplasm of pancreas	FGF2	1.0	
Triple Negative Breast Neoplasms	EGF	1.0	
Triple Negative Breast Neoplasms	FGF2	1.0	
Melanocytic nevus of skin	EGF	1.0	
Melanocytic nevus of skin	FGF2	1.0	
Interstitial fibrosis	EGF	1.0	
Interstitial fibrosis	FGF2	1.0	
Hereditary macular dystrophy	EGF	1.0	
Peritoneal Mesothelioma	EGF	1.0	
Morphologically altered structure	EGF	1.0	
Cardiovascular morbidity	FGF2	1.0	
Cystic Kidney Diseases	FGF2	1.0	
Achondroplasia	FGF2	1.0	
Adrenal Gland Hyperfunction	EGF	1.0	
Dupuytren Contracture	EGF	1.0	
Multiple Endocrine Neoplasia Type 2b	EGF	1.0	
Thrombosis of retinal vein	FGF2	1.0	
Squamous cell carcinoma of the hypopharynx	EGF	1.0	
Familial X-linked hypophosphatemic vitamin D refractory rickets	FGF2	1.0	
Squamous Cell Neoplasms	EGF	1.0	
Pituitary dependent hypercortisolism	EGF	1.0	
gastritis h pylori	EGF	1.0	
Protein S deficiency	EGF	1.0	
Pancreatic fibrosis	EGF	1.0	
Intermittent claudication	FGF2	1.0	
Spinal cord compression	FGF2	1.0	
Gastrinoma	EGF	1.0	
Hypohidrotic X-linked ectodermal dysplasia	EGF	1.0	
Arteriovenous hemangioma	FGF2	1.0	
Pleomorphic adenoma of salivary gland	FGF2	1.0	
Mucopolysaccharidosis, MPS-IV-B	EGF	1.0	
Recessive dystrophic epidermolysis bullosa	EGF	1.0	
Prostate Cancer, Hereditary, 7	EGF	1.0	
Comedone	EGF	1.0	
Sentinel node (disorder)	EGF	1.0	
Osteomalacia	FGF2	1.0	
Peptic Ulcer Hemorrhage	FGF2	1.0	
Bull's eye macular dystrophy	EGF	1.0	
Noonan syndrome with multiple lentigines	EGF	1.0	
Chronic viral hepatitis	EGF	1.0	
Costello syndrome	EGF	1.0	
Mammary adenocarcinoma	EGF	1.0	
Ectopia lentis, isolated autosomal recessive	EGF	1.0	
Pregnancy in Diabetics	FGF2	1.0	
Prostate cancer stage C	EGF	1.0	
Intracranial glioma	EGF	1.0	
Obstructive nephropathy	EGF	1.0	
Chronic rejection of renal transplant	EGF	1.0	
CADASIL	EGF	1.0	
Carcinosarcoma	EGF	1.0	
Erythroblastosis	EGF	1.0	
Primary malignant neoplasm of brain	FGF2	1.0	
Platelet-type bleeding disorder 15	EGF	1.0	
Chloracne	EGF	1.0	
Chronic interstitial cystitis	EGF	1.0	
Tumor-Associated Vasculature	FGF2	1.0	
AIDS Dementia Complex	FGF2	1.0	
Tubulointerstitial nephritis	FGF2	1.0	
Autosomal recessive polycystic kidney disease	EGF	1.0	
Manic	EGF	1.0	
Mammary Carcinoma, Human	EGF	1.0	
CARCINOMA OF VULVA	EGF	1.0	
Choroidal Neovascularization	FGF2	1.0	
Hereditary factor IX deficiency disease	EGF	1.0	
Neoplasm of the gallbladder	EGF	1.0	
Cystic kidney	EGF	1.0	
Rous Sarcoma	EGF	1.0	
Hepatocellular adenoma	EGF	1.0	
Acute Cerebrovascular Accidents	FGF2	1.0	
Atypical teratoid/rhabdoid tumor	EGF	1.0	
Prenatal Exposure Delayed Effects	FGF2	1.0	
Neurofibromas	EGF	1.0	
Cervical Adenocarcinoma	EGF	1.0	
Female Breast Carcinoma	EGF	1.0	
Cleft palate with cleft lip	FGF2	1.0	
Nerve Sheath Tumors	EGF	1.0	
Leukemia, Large Granular Lymphocytic	FGF2	1.0	
Marfan syndrome	EGF	1.0	
Carcinoma, Neuroendocrine	EGF	1.0	
Multiple endocrine neoplasia, type 4	FGF2	1.0	
Neurofibromatosis 2	EGF	1.0	
Russell-Silver syndrome	EGF	1.0	
Endometriosis of uterus	FGF2	1.0	
Photoreceptor degeneration	FGF2	1.0	
Medullary carcinoma	EGF	1.0	
Female pseudohermaphroditism	EGF	1.0	
Malignant Fibrous Histiocytoma	EGF	1.0	
Lymphangiomyomatosis	EGF	1.0	
Cowden syndrome 1	EGF	1.0	
Oral Submucous Fibrosis	FGF2	1.0	
Desmoid tumor	EGF	1.0	
CNS symptom	EGF	1.0	
Ovarian adenocarcinoma	FGF2	1.0	
Hydatidiform mole, recurrent, 1, 231090 (3)	EGF	1.0	
Helminthiasis	EGF	1.0	
Vitreoretinopathy, neovascular inflammatory, 193235 (3)	EGF	1.0	
Diaphragmatic hernia	FGF2	1.0	
gliosarcoma	EGF	1.0	
Ameloblastoma	EGF	1.0	
Angiogenic Switch	FGF2	1.0	
Psychoses, Substance-Induced	FGF2	1.0	
Proliferative diabetic retinopathy	FGF2	1.0	
Limb ischemia	FGF2	1.0	
Giant cell tumor of bone	EGF	1.0	
Nasopharyngeal cancer recurrent	EGF	1.0	
Contractures involving the joints of the feet	FGF2	1.0	
Polyposis syndrome, mixed hereditary 1 (4)	EGF	1.0	
Bronchitis, Chronic	EGF	1.0	
Pleural Effusion, Malignant	FGF2	1.0	
Adenovirus Infections	EGF	1.0	
Myeloid neoplasm with beta-type platelet-derived growth factor receptor gene rearrangement	FGF2	1.0	
Chronic gastritis	EGF	1.0	
Brain Infarction	FGF2	1.0	
Epithelial hyperplasia of skin	EGF	1.0	
Scar conditions and fibrosis of skin	EGF	1.0	
Duodenal Ulcer	EGF	1.0	
Metaplasia	EGF	1.0	
Rash and Dermatitis Adverse Event Associated with Chemoradiation	FGF2	1.0	
Multiple Endocrine Neoplasia Type 1	FGF2	1.0	
Hydatidiform mole, recurrent, 2	EGF	1.0	
Chordoma	FGF2	1.0	
Dementia, Vascular	EGF	1.0	
{Diphtheria, susceptibility to} (1)	EGF	1.0	
Gastrointestinal Diseases	FGF2	1.0	
granulosa cell tumor	EGF	1.0	
Intestinal polyp	EGF	1.0	
Candidiasis, familial, 9	EGF	1.0	
Cholera	EGF	1.0	
Gliosis	FGF2	1.0	
Pterygium	EGF	1.0	
Carcinoid tumor no ICD-O subtype	EGF	1.0	
Diabetic Angiopathies	FGF2	1.0	
Tumor Promotion	EGF	1.0	
Necrotizing Enterocolitis	EGF	1.0	
Vestibular Schwannoma	FGF2	1.0	
Recurrent urinary tract infections	EGF	1.0	
Oral Cavity Carcinoma	EGF	1.0	
X-linked ichthyosis with steryl-sulfatase deficiency	EGF	1.0	
Arteriovenous malformation	FGF2	1.0	
Adenocarcinoma, Clear Cell	EGF	1.0	
Inflammatory Breast Carcinoma	EGF	1.0	
Prolactinoma, familial	FGF2	1.0	
Biliary Atresia	EGF	1.0	
Marijuana Abuse	FGF2	1.0	
Hyperplastic Polyp	EGF	1.0	
Teratocarcinoma	EGF	1.0	
Melanoma, B16	FGF2	1.0	
Myelofibrosis	FGF2	1.0	
Neoplasm of the rectum	EGF	1.0	
High grade serous carcinoma	EGF	1.0	
Rhabdoid Tumor of the Kidney	EGF	1.0	
Teratoma	FGF2	1.0	
Severe Myopia	FGF2	1.0	
Idiopathic thrombocytopenic purpura	FGF2	1.0	
Abnormality of divalent inorganic cation homeostasis	EGF	1.0	
Intracranial Aneurysm	FGF2	1.0	
Ovarian cyst	EGF	1.0	
Breast adenocarcinoma	EGF	1.0	
Cocaine-Related Disorders	FGF2	1.0	
Squamous cell carcinoma of tongue	EGF	1.0	
Bilateral cataracts (disorder)	EGF	1.0	
Ependymoma	EGF	1.0	
Primary Effusion Lymphoma	FGF2	1.0	
Carcinoma, Endometrioid	EGF	1.0	
Pancytopenia	FGF2	1.0	
Impotence	FGF2	1.0	
Hypodontia	EGF	1.0	
Schwannoma	EGF	1.0	
Transitional cell carcinoma of the bladder	EGF	1.0	
Metastatic malignant neoplasm to brain	EGF	1.0	
 {Aerodigestive tract cancer, squamous cell, alcohol-related, protection against} (3)	EGF	1.0	
Differentiated Thyroid Gland Carcinoma	FGF2	1.0	
Anaplastic Oligodendroglioma	FGF2	1.0	
Pleural effusion	FGF2	1.0	
Anaplastic astrocytoma	FGF2	1.0	
Lung Diseases, Interstitial	EGF	1.0	
Neoplasm of the nervous system	EGF	1.0	
Testicular Neoplasms	EGF	1.0	
Respiratory Distress Syndrome, Adult	EGF	1.0	
Hyperplasia	FGF2	1.0	
Mycosis Fungoides	FGF2	1.0	
Neoplastic Cell Transformation	EGF	1.0	
Monoclonal Gammopathy of Undetermined Significance	FGF2	1.0	
Neurodegeneration with brain iron accumulation	FGF2	1.0	
Arthropathy	FGF2	1.0	
Polycystic kidney disease, autosomal dominant	EGF	1.0	
Essential thrombocythemia	FGF2	1.0	
invasive cancer	FGF2	1.0	
{Aneurysm, familial abdominal 3} (2)	FGF2	1.0	
Peripheral Arterial Disease	FGF2	1.0	
Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation	EGF	1.0	
Neurofibromatosis, type 1, 162200 (3)	EGF	1.0	
Ureteral obstruction	EGF	1.0	
Invasive Carcinoma	EGF	1.0	
Oligospermia	EGF	1.0	
androgen independent prostate cancer	EGF	1.0	
Hemangioma	FGF2	1.0	
Hydronephrosis	EGF	1.0	
Insulinoma	EGF	1.0	
Growth retardation, intellectual developmental disorder, hypotonia, and hepatopathy, 617093 (3)	EGF	1.0	
Monosomy	EGF	1.0	
Polycystic Kidney, Autosomal Dominant	EGF	1.0	
VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding)	FGF2	1.0	
Adenocarcinoma of prostate	EGF	1.0	
Carotid Stenosis	EGF	1.0	
Acquired Immunodeficiency Syndrome	FGF2	1.0	
Squamous cell carcinoma of the skin	EGF	1.0	
Lymphatic Metastasis	EGF	1.0	
Neoplasm Invasiveness	EGF	1.0	
Hematopoietic Neoplasms	FGF2	1.0	
Tumor necrosis	EGF	1.0	
Aplastic anemia	EGF	1.0	
Cytomegalovirus Infections	EGF	1.0	
Keloid	FGF2	1.0	
Nephritis	FGF2	1.0	
Primary Myelofibrosis	FGF2	1.0	
Trisomy	EGF	1.0	
Tetralogy of Fallot	EGF	1.0	
Seborheic dermatitis	EGF	1.0	
Familial hypercholesterolemia	EGF	1.0	
Secondary hyperparathyroidism	EGF	1.0	
Tumor Initiation	EGF	1.0	
Carcinoid tumor	EGF	1.0	
Eclampsia	EGF	1.0	
Cyst	EGF	1.0	
Kaposi's sarcoma	FGF2	1.0	
Spinal muscular atrophy with congenital bone fractures 2	EGF	1.0	
Adenocarcinoma of the large intestine	EGF	1.0	
Fibrosis	FGF2	1.0	
Well Differentiated Oligodendroglioma	FGF2	1.0	
Tuberous sclerosis syndrome	EGF	1.0	
Abnormality of cation homeostasis	EGF	1.0	
Neoplasms, Second Primary	FGF2	1.0	
Primary cutaneous marginal zone B-cell lymphoma	EGF	1.0	
Fetal Membranes, Premature Rupture	FGF2	1.0	
Chorioamnionitis	FGF2	1.0	
Papilloma	EGF	1.0	
Adenoid Cystic Carcinoma	FGF2	1.0	
Medullary thyroid carcinoma	EGF	1.0	
Premature Obstetric Labor	FGF2	1.0	
Maternal diabetes	FGF2	1.0	
Pulmonary Emphysema	EGF	1.0	
Cervical intraepithelial neoplasia (Cervical dysplasia)	FGF2	1.0	
Benign neoplasm of other endocrine glands	EGF	1.0	
Abnormality of ion homeostasis	EGF	1.0	
Endothelial dysfunction	FGF2	1.0	
Meningioma, benign, no ICD-O subtype	EGF	1.0	
Restenosis	EGF	1.0	
Chondrosarcoma	FGF2	1.0	
Metastatic Prostate Carcinoma	EGF	1.0	
Carcinoma, Papillary	EGF	1.0	
Nasal polyposis	FGF2	1.0	
Dermal atrophy	FGF2	1.0	
Adenocarcinoma of colon	EGF	1.0	
Pleural Mesothelioma	EGF	1.0	
Vitiligo	FGF2	1.0	
Myeloproliferative Disorders	FGF2	1.0	
Malignant gastrointestinal tract tumors	EGF	1.0	
Neuroendocrine neoplasm	EGF	1.0	
Fibrosarcoma	FGF2	1.0	
Recurrent bacterial infection	FGF2	1.0	
Adenoma of large intestine	FGF2	1.0	
Gastroesophageal reflux	EGF	1.0	
Pheochromocytoma	EGF	1.0	
Spontaneous abortion	EGF	1.0	
Nephrotic syndrome, type 5, with or without ocular abnormalities	FGF2	1.0	
RETINAL DYSTROPHY WITH OR WITHOUT MACULAR STAPHYLOMA	FGF2	1.0	
Experimental Organism Basal Cell Carcinoma	FGF2	1.0	
Gastrointestinal Neoplasms	EGF	1.0	
Ewing's sarcoma	FGF2	1.0	
Diabetic Retinopathy	FGF2	1.0	
Acute kidney injury	EGF	1.0	
Hepatitis B, Chronic	EGF	1.0	
Cardiomegaly	FGF2	1.0	
Epithelioma	EGF	1.0	
polyps	EGF	1.0	
Rectal Carcinoma	EGF	1.0	
Retinal degeneration	FGF2	1.0	
Ischaemic cerebral infarction	FGF2	1.0	
Helicobacter pylori infection	EGF	1.0	
Dementia familial British	EGF	1.0	
Huntington's chorea	FGF2	1.0	
Cancer Cell Growth	EGF	1.0	
Mood Disorders	FGF2	1.0	
Periodontitis	EGF	1.0	
Metastatic melanoma	FGF2	1.0	
Juvenile idiopathic arthritis, enthesitis related arthritis	EGF	1.0	
Arrhythmias, Cardiac	EGF	1.0	
Gastrointestinal stromal tumor	FGF2	1.0	
Carcinoma breast stage IV	EGF	1.0	
Cleft Lip	FGF2	1.0	
Renal neoplasm	EGF	1.0	
Epiphyseal dysplasia, multiple, with myopia and conductive deafness	FGF2	1.0	
Renal Insufficiency, Chronic	EGF	1.0	
Exanthema	EGF	1.0	
Clear cell renal cell carcinoma	EGF	1.0	
Invasive breast carcinoma	EGF	1.0	
Premature Birth	FGF2	1.0	
Pulmonary Disease, Chronic Obstructive	EGF	1.0	
Hereditary pancreatitis	EGF	1.0	
Rhabdomyosarcoma alveolar	EGF	1.0	
B Acute Lymphoblastic Leukemia with t(9;22)(q34;q11.2); BCR-ABL1	FGF2	1.0	
Heart Diseases	FGF2	1.0	
Experimental Autoimmune Encephalomyelitis	FGF2	1.0	
Cholangiocarcinoma	EGF	1.0	
Ischemic stroke	FGF2	1.0	
Hodgkin Disease	FGF2	1.0	
Vascular Diseases	FGF2	1.0	
Lip and Oral Cavity Carcinoma	EGF	1.0	
Cancer of mouth	EGF	1.0	
Retinopathy	FGF2	1.0	
Glioblastoma multiforme	EGF	1.0	
Celiac Disease	EGF	1.0	
Neoplasm of the skin	EGF	1.0	
Cystic Fibrosis	EGF	1.0	
Hyperglycemia	FGF2	1.0	
Non-Neoplastic Disorder	EGF	1.0	
Urinary Bladder Neoplasms	FGF2	1.0	
Hepatocarcinogenesis	EGF	1.0	
Retinoblastoma	FGF2	1.0	
Eczema	EGF	1.0	
Atrial septal defect	EGF	1.0	
Dementia	EGF	1.0	
Acute myocardial ischemia	FGF2	1.0	
Combined Hepatocellular Carcinoma and Cholangiocarcinoma	EGF	1.0	
Malaria	EGF	1.0	
Depressive Disorder	FGF2	1.0	
Medulloblastoma	FGF2	1.0	
Severe combined immunodeficiency due to ADA deficiency	FGF2	1.0	
Xenograft Model	FGF2	1.0	
{Unipolar depression, susceptibility to}, 608516 (3)	FGF2	1.0	
Non-Hodgkin lymphoma	FGF2	1.0	
Dermatitis, Atopic	EGF	1.0	
Pancreatic Ductal Adenocarcinoma	EGF	1.0	
Immunodeficiency due to defect in CD3-gamma	EGF	1.0	
Liver Diseases	EGF	1.0	
Hepatic cancer metastatic	EGF	1.0	
Kidney Failure, Chronic	EGF	1.0	
Anemia	FGF2	1.0	
Scoliosis	FGF2	1.0	
Osteoporosis	FGF2	1.0	
IgA nephropathy, susceptibility to, 3	EGF	1.0	
B-cell lymphoma	FGF2	1.0	
Leukemogenesis	FGF2	1.0	
Nasopharyngeal carcinoma, susceptibility to, 3	EGF	1.0	
Alcohol dependence	EGF	1.0	
Colitis, Ulcerative	EGF	1.0	
Cataract, autosomal recessive congenital 5	EGF	1.0	
Hepatitis C	EGF	1.0	
